Patient information leaflet

If you market a medicine, it must be supplied together with a patient information leaflet. This leaflet contains product information for the patient in understandable language. The information leaflet must be approved by the Medicines Evaluation Board (CBG). Information leaflets relating to new medicines or to medicines that have changed significantly must be submitted to consumer panels.